Advanced-stage hepatocellular carcinoma is currently treated with various anti-PD-(L)1 antibody-containing regimens. Now, a triplet combining the anti-TIGIT antibody tiragolumab with one of these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback